Most studies show benefits with 2,000 to 5,000 mg per day, often split into two or three smaller doses
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury
Polymorphisms within the COL5A1 gene and regulators of the extracellular matrix modify the risk of Achilles tendon pathology in a British case-control study
There is no indication of medical efficacy or, in particular, weight loss
Not if we create a scene for everyone else and then leave it to them. The CEO characterized 2025 as a critical year for us to recognize this: were no longer on our own, and we need to hurry up. He emphasized that Novo Nordisk cannot continue operating as it did in the previous couple of years, where we were left alone just because we had a head start. When Novo Nordisk first entered obesity research three decades ago, Doustdar noted, many of our peers who have sat in this stage now or will sit here in the future were making fun of us
It is essential to inform your GP about all medications you are taking to ensure safe, appropriate treatment tailored to your individual circumstances
